Given WHO’s ambitious goal to eliminate viral hepatitis by 2030, national HBV screening for Turkish FGM should be implemented and might be considered in SGM not covered by primary prevention strategies, taking into account the asymptomatic nature of disease and misleading normal levels of ALT. This evidence concerns the gene GPT and animal viral hepatitis.